Belgian Study to Assess the Efficacy and Safety of the RESTORER Iliac Stent for Treatment of Aorto-iliac Lesions.

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 131 participants.

Also called NCT05293002

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 131 participants (planned count) (from the registry)
Sponsor
  • ID3 Medical Registry lists this organization as the lead sponsor
Registry
  • NCT NCT05293002
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Belgium (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05293002. Allocation not applicable; no masking; primary purpose treatment. Start 2022-06-13 (actual); primary completion 2025-07-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Belgian Study to Assess the Efficacy and Safety of the RESTORER Iliac Stent for Treatment of Aorto-iliac Lesions.
Acronym
BARISTA
Condition
Peripheral Arterial Disease
Intervention (Device)
Restorer Iliac Stent System
Lead sponsor
ID3 Medical (class: other)

Record details

Record id
cardio:ct-nct05293002
Content hash
341966865e70444dcd0125a25d701b558a3f90b36d2ea913c76c62483ee3ac56